emodin has been researched along with 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Al-Lawati, I; Ali, BH; Nemmar, A; Waly, MI | 1 |
1 other study(ies) available for emodin and 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid
| Article | Year |
|---|---|
Protective effects of emodin against cisplatin-induced oxidative stress in cultured human kidney (HEK 293) cells.
Topics: Antineoplastic Agents; Antioxidants; Biphenyl Compounds; Cell Survival; Chromans; Cisplatin; Coloring Agents; Emodin; Enzyme Inhibitors; Free Radical Scavengers; Free Radicals; HEK293 Cells; Humans; Oxidative Stress; Picrates | 2013 |